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Setting priorities for knowledge translation
of Cochrane reviews for health equity:
Evidence for Equity
Peter Tugwell1,2,3*, Jennifer Petkovic4, Vivian Welch4, Jennifer Vincent4, Zulfiqar A. Bhutta5, Rachel Churchill6,
Don deSavigny7, Lawrence Mbuagbaw8 and Tomas Pantoja9
Abstract
Background: A focus on equity in health can be seen in many global development goals and reports, research and
international declarations. With the development of a relevant framework and methods, the Campbell and Cochrane
Equity Methods Group has encouraged the application of an ‘equity lens’ to systematic reviews, and many
organizations publish reviews intended to address health equity.
The purpose of the Evidence for Equity (E4E) project was to conduct a priority-setting exercise and apply an equity lens
by developing a knowledge translation product comprising summaries of systematic reviews from the Cochrane
Library. E4E translates evidence from systematic reviews into ‘friendly front end’ summaries for policy makers.
Methods: The following topic areas with high burdens of disease globally, were selected for the pilot: diabetes/obesity,
HIV/AIDS, malaria, nutrition, and mental health/depression. For each topic area, a “stakeholder panel” was assembled
that included policymakers and researchers. A systematic search of Cochrane reviews was conducted for each area to
identify equity-relevant interventions with a meaningful impact. Panel chairs developed a rating sheet which was used
by all panels to rank the importance of these interventions by: 1) Ease of Implementation; 2) Health System
Requirements; 3)Universality/Generalizability/Share of Burden; and 4) Impact on Inequities/Effect on equity.
The ratings of panel members were averaged for each intervention and criterion, and interventions were ordered
according to the average overall ratings.
Results: Stakeholder panels identified the top 10 interventions from their respective topic areas. The evidence on these
interventions is being summarized with an equity focus and the results posted online, at http://methods.cochrane.org/
equity/e4e-series.
Conclusions: This method provides an explicit approach to setting priorities by systematic review groups and funders
for providing decision makers with evidence for the most important equity-relevant interventions.
Keywords: Equity, Systematic reviews, Priority setting
Background
The number of reports of systematic reviews of re-
search has increased from about 80 a year in the late
1980s to more than 8000 a year today [1]. This makes
it very difficult for decision makers to keep abreast of
the latest evidence. The Campbell and Cochrane
Equity Group is committed to finding ways of helping
decision makers access and use the evidence on inter-
ventions that has impact on health inequities. Health
inequities are avoidable differences in health out-
comes [2]. The importance of equity in health, well-
being and wealth is increasingly accepted globally,
and it underpins research, global development goals
and reports, and international declarations [3–9]. The
Campbell and Cochrane Collaborations, and other
groups, such as the Alliance for Health Policy and
Systems Research and the International Initiative for
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Impact Evaluation (3ie), publish systematic reviews of
the evidence for what works and what does not.
There has been an increased emphasis on health
equity in systematic reviews with the establishment of
a Campbell and Cochrane Equity Methods Group
(Equity Methods Group), whose members have pro-
vided a framework [10] and methods [11, 12] for ap-
plying an ‘equity lens’ to systematic reviews.
However, there is an ongoing need for dissemination
and integrated knowledge translation of systematic re-
views, to make users aware of knowledge and facilitate
its use to improve health and health systems [13–17]. A
number of initiatives are currently addressing this chal-
lenge, such as the following:
 Evidence Aid review summaries for major healthcare
emergencies, including disasters
(www.evidenceaid.org/) [18];
 Supporting Policy-relevant Reviews and Trials
(SUPPORT) evidence summaries of health systems
interventions in low- and middle-income countries,
which are based on a simplified version of the
Cochrane Summary of Findings Tables
(www.supportsummaries.org/);
 Evidence summaries developed by the International
Initiative for Impact Evaluation (3ie) in the areas of
health, nutrition and population which emphasize
photographs and text and are exploring the use of
expert commentaries (http://www.3ieimpact.org/en/
inform-policy/health-nutrition-and-population/);
 Syntheses of research evidence about governance,
financial and delivery arrangements within health
systems, and about implementation strategies that
can support change in health systems
(www.healthsystemsevidence.org/); and
 Countdown to 2030 produces thematic or country-
specific briefing notes for policymakers on topics
related to maternal, newborn, and child survival
(http://countdown2030.org/reports-and-articles/
briefing-notes);
These websites and databases include varying
amounts of information related to health equity,
such as ‘what works’ for disadvantaged individuals
and groups. We developed this Evidence for Equity
(E4E) project to focus specifically on equity-relevant
interventions. E4E applies an equity lens to system-
atic reviews through a knowledge translation prod-
uct comprising summaries of systematic reviews
from the Cochrane and Campbell libraries. E4E
translates evidence from systematic reviews into
“friendly front-end” summaries for policy makers.
Building on these other collections of summaries,
E4E aims to summarize evidence on interventions
that may reduce inequities. The aim of this special
collection of systematic review summaries is to pro-
vide policy makers, clinicians, and other practi-
tioners, particularly those working in resource-
limited settings, with easily accessible, high quality
evidence on relevant interventions.
Despite the increased recognition of the importance of
knowledge translation of systematic reviews which
summarize the totality of the evidence, there is very little
done to prioritize topics for focused knowledge transla-
tion efforts. The objective of this study was to identify
which systematic reviews were highest priority for know-
ledge translation, with a focus on promoting health
equity, in collaboration with policymakers and program
managers.
Take Home Messages
1. For policy makers and program managers in high- or low-/middle-
income countries who want to make evidence-based decisions on
equity-focused interventions, it is challenging to find evidence on in-
terventions that are effective.
2. This pilot project assessed priority setting methods to identify priority
interventions from Cochrane systematic reviews for which there is
evidence of a benefit in five topic areas: diabetes/obesity, HIV/AIDS,
malaria, nutrition, and depression.
3. This paper presents criteria for priority setting for systematic review
groups and funders which may help identify the most important
equity-relevant interventions.
Methods
A steering group of individuals with extensive
experience with systematic reviews and knowledge
translation methods met face-to-face in London, Eng-
land in February of 2012. During a two-day meeting,
the group decided to focus on a combination of pri-
orities using the Millennium Development Goals as a
starting point and expanding on these to also include
non-communicable diseases. This resulted in the se-
lection of the following pilot topic areas, each of
which has a high burden of disease globally, as indi-
cated by associated disability-adjusted life years
(DALYs):
 Diabetes/obesity: For diabetes mellitus, over 59
million DALYs (2.2% total DALYs) as of 201216
 HIV/AIDS: Almost 92 million DALYs (3.4% total
DALYs) as of 201216
 Malaria: Over 55 million DALYs (2.0% total DALYs)
as of 201216
 Nutrition: For children under 5 years of age,
maternal and child undernutrition is responsible for
11% of global DALYs as of 2012 [19]
 Mental health/depression: For unipolar depressive
disorders, 76.5 million DALYs (2.8% total DALYs) as
of 2012 [20]
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In 2015, the United Nations created the global
Sustainable Development Goals (SDGs); a group of 17
goals to be met by 2030 [21]. The topic areas listed
above are still relevant to the SDGs. Goal number 3
addresses all health priorities and includes reproductive,
maternal and child health; communicable and non-
communicable diseases; as well as access for all to safe,
effective, and affordable medicines and vaccines [21]. In
addition, goal number 10 is to reduce inequalities within
and between countries and focuses on eliminating in-
equities based on age, sex, disability, race, ethnicity, ori-
gin, religion, and socioeconomic or other status.
Systematic reviews on these five topic areas were
retrieved through a search in the Cochrane Library (via
Wiley (http://www.cochranelibrary.com/), up to 2013,
Issue 6) using relevant key words in the title field and
limiting the start date to 2008. The exact search
strategies are reported in Additional file 1.
Two independent screeners reviewed the results
section (Data and Analysis) of the Cochrane reviews to
identify: a) any statistically significant difference in
mortality; b) for any other categorical morbidity
outcomes besides mortality, Odds Ratio (OR) or Relative
Risk (RR) greater than 2 or less than 0.5; [22] c) all
statistically significant continuous morbidity outcomes
(SMD, MD) that when transformed into ORs were
greater than 2. Surrogate outcomes and non-statistically
significant effects were excluded. Details of the popula-
tion, intervention, comparisons, outcomes, and effect
size were extracted.
Negative effect sizes that demonstrated benefit were
converted to a positive value, by reversing the scale for
continuous outcomes or by taking the inverse of
dichotomous outcomes (e.g. >1). All effect sizes were
converted to odds ratios to allow for comparison across
reviews using the formulae provided in the Cochrane
Handbook [23]. The results are described as the
“converted effect size and confidence interval”.
Five “Stakeholder Panels” were assembled to participate
in the priority-setting exercise, each addressing one of the
five condition-related topic areas listed above. For each
panel, a chair(s) was recruited based on their expertise in
one or both conditions and in conducting systematic re-
views. The chair(s) helped identify and approach five other
policy makers and researchers (stakeholders) to join the
panel. Members of these panels were purposefully selected
to ensure a variety of policymakers (e.g. national, regional,
civil society, NGO) from both HIC and LMIC, with re-
sponsibility in the topic area of their panel and with inter-
est in evidence-based policy making.
Stakeholder panel chairs reviewed the initial list of
potential interventions and outcomes and eliminated: a)
those which are no longer used b) those which could
not be implemented globally due to prohibitive costs,
especially in resource-constrained settings c) interven-
tions whose outcomes were not meaningfully important.
Chairs collaborated on the development of a rating
sheet which was used by other panel members to rank the
interventions on a scale from 0 to 4, with 4 denoting an
optimal intervention, for four criteria. These criteria were
developed based on the Child Health and Nutrition
Research Initiative (CHNRI) priority setting exercise [24].
A. Ease of Implementation: Ease with which the
intervention can be implemented. Consider whether
there is sufficient capacity to implement the
intervention.
B. Health System Requirements: Potential effect on the
health system. Consider the level of difficulty with
intervention delivery, the infrastructure required
(human resources, facilities, etc.). Consider the
resources available and whether the intervention is
affordable.
C. Universality/Generalizability/Share of Burden:
Relevance of the intervention to other settings. Is
the intervention relevant to most countries?
Consider whether the intervention poses safety
concerns and whether these may be different in
different settings. Rank lower for a less generalizable
intervention, or one that applies only to a specific
population.
D. Impact on Inequities/Effect on equity: Does the
distribution of the disease burden mainly affect the
disadvantaged? Are the disadvantaged most likely to
benefit from the intervention? Will the intervention
improve equity in disease burden distribution
long-term? Rank lower for interventions that may
increase inequities.
Stakeholder panel members were also asked to note any
safety concerns. Finally, they were asked to give an overall
rating for each intervention (from 1 to 4 where 1 was the
least important intervention and 4 was the most
important intervention). Instructions given to stakeholder
panel members are provided in Additional file 2.
Lastly, the ratings of all panel members were averaged
for each intervention and criteria. We converted the
average rating into a score out of 100 for ease of
interpretation. This step is different from the CHNRI
method which calculates the scores divided by the
number of received answers to obtain a percentage of
agreement [24]. We ordered interventions according to
the average overall rating. We provided these rank-
ordered lists to all panel members.
Results
Each stakeholder panel consisted of at least six members,
including the panel chair plus five or more additional
Tugwell et al. International Journal for Equity in Health  (2017) 16:208 Page 3 of 8
experts. The characteristics of our stakeholders are listed
in Table 1.
Eligible systematic reviews, reaching criteria for
important effects
We reviewed all systematic reviews in the areas of
depression, malaria, nutrition, diabetes/obesity and HIV
in the Cochrane Library from 2008 to 2013. Of these, 96
reviews met the criteria for being relevant to current
practice, having an odds ratio > 2 for morbidity, and/or
for having a meaningful impact on mortality.
Consensus ratings
Stakeholder panel members reported that the wide
range of interventions and outcomes made ranking
difficult and in some cases reported that they gave more
priority to interventions with which they were more
familiar. We needed to provide additional information
for some panel members to complete their rankings.
Panel members also reported having some difficulty
judging the intervention for some of the criteria without
having a particular context or without more details
about the intervention (e.g. frequency, delivery method).
Additional judgment was needed where interventions
may be provided in combinations that may differ
depending on the local context. In such situations, panel
members were encouraged to think of the real-life prac-
ticalities in one of the countries with a high burden of
the condition of interest.
Panel members used the full range of the scale from 1
to 4 for each criterion. We did not find evidence of
bimodal distributions in the scores that would suggest
disagreement within the panel ratings. Furthermore,
panel members reached consensus on the top 10
interventions in each panel easily.
Top-ranked interventions for knowledge translation
Table 2 shows the prioritisation results for diabetes/
obesity. See Additional file 3 for the same tables for the
other 4 conditions. These show the ratings by the panels
on the degree that these systematic reviews merited
focus for knowledge translation based on their
importance for improving the health of the
disadvantaged, based on the four criteria of health
system effects, generalizability, impact on health equity
and ease of implementation.
Discussion
With the realisation that single studies, however large,
should not drive policy due to the fact that they may not
be replicable [25] there has been an exponential increase
in systematic reviews. Research community members,
especially those working on reducing health inequities,
have a responsibility to inform policymakers and their
advisors who make decisions on which systematic
reviews should be prioritized for knowledge translation
for the benefit of the most vulnerable members of their
populations. Such global exercises need to be sensitive
to major regional differences in needs and perceived
priorities.
Our approach differs from other priority-setting exer-
cises because we chose to focus on prioritizing know-
ledge translation of completed systematic reviews that
have the potential to promote health equity. We also in-
volved those who need and use this evidence with re-
searchers and publishers in order to meet the
information needs for those making decisions related to
equity. The intent is to provide an international platform
to deliver summaries from systematic reviews on inter-
ventions that impact on health in disadvantaged popula-
tions. The target audience includes policymakers,
clinicians, regulators, and the general public. This E4E
initiative addresses the criticism that Cochrane reviews
fail to draw useful conclusions [26] and instead call for
Table 1 Characteristics of Participants in all Stakeholder Panels
N (%)
Total 32
Male 26 (81.25)
Female 6 (18.75)
Country
High-income 21 (65.6)
Low- and middle-income 11 (34.4)
Australia 1 (3.1)
Argentina 1 (3.1)
Cameroon 2 (6.25)
Canada 6 (18.8)
Chile 1 (3.1)
India 1 (3.1)
Italy 1 (3.1)
Kenya 2 (6.25)
Lebanon 1 (3.1)
Pakistan 1 (3.1)
Peru 1 (3.1)
South Africa 3 (9.4)
Switzerland 3 (9.4)
US 5 (15.63)
UK 3 (9.4)
Role
Clinician 12 (37.5)
Policy 22 (68.8)
Researcher 30 (93.8)
Note: percentages do not add to 100 since stakeholders could have
multiple roles
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Table 2 Diabetes/obesity top 10 interventions
Intervention Outcome Feasibilitya Deliverabilityb Universalityc Effect on Equityd Overall Rating (%)
1 Sulphonylureas versus insulin All-cause mortality; best-worst
case scenario
Range: 2–4 Total: 75
Rank: 3
Range: 2–4 Total: 75
Rank: 1
Range: 2–4 Total: 75
Rank: 5
Range: 2–4 Total: 70.83
Rank:7
76.67 Rank: 1
2 metformin vs sulphonylureas
or insulin.
all cause mortality Range: 2–4 Total: 87.5
Rank: 1
Range: 2–4 Total: 66.67
Rank: 5
Range: 2–4 Total: 75
Rank: 5
Range: 2–4 Total: 70.83
Rank: 7
75 Rank: 2
3 ACEi versus placebo/no treatment All cause mortality Range: 2–4 Total: 80
Rank: 2
Range: 2–4 Total: 75
Rank:1
Range: 3–4 Total: 85
Rank: 1
Range: 2–3 Total: 70
Rank: 8
71.15 Rank: 3
4 Low salt vs high salt diet Systolic BP Range: 1–3 Total: 62.5
Rank: 9
Range: 1–4 Total: 71.88
Rank: 2
Range: 2–3 Total: 59.38
Rank: 14
Range: 2–4 Total: 71.88
Rank: 5
77.5 Rank: 4
5 Exercise vs no exercise Glycated haemoglobin (%) Range: 1–3 Total: 62.5
Rank: 9
Range: 2–4 Total: 71.88
Rank: 2
Range: 2–3 Total: 71.88
Rank: 6
Range: 2–3 Total: 68.75
Rank: 9
73 Rank: 5
6 Group-based diabetes education
programme versus individual
routine treatment
reduction in diabetes medication Range: 1–4 Total: 53.13
Rank: 15
Range: 2–4 Total: 68.75
Rank: 4
Range: 2–3 Total: 65.63
Rank: 9
Range: 2–4 Total: 81.25
Rank: 1
73 Rank: 5
7 Effects of intensive versus brief
education in high risk patient
samples
Foot ulcer incidence (1-year
follow-up)
Range: 1–3 Total: 50
Rank: 16
Range: 2–4 Total: 65.63
Rank: 6
Range: 2–4 Total: 65.63
Rank: 9
Range: 2–4 Total: 78.13
Rank: 3
71 Rank: 6
8 Tight-moderate versus loose
glycaemic control
Pre-eclampsia Range: 0–3 Total: 46.43
Rank: 18
Range: 0–3 Total: 50
Rank: 19
Range: 0–3 Total: 53.57
Rank: 18
Range: 0–3 Total: 53.57
Rank: 18
70.31 Rank: 7
Very tight versus tight-moderate
glycaemic control
Maternal hospitalisation (days)
Tight versus moderate glycaemic
control
Maternal hypoglycaemia in first
half of pregnancy
9 low glycaemic index (LGI) vs high
glycaemic index
large-for-gestational age Range: 2–4 Total: 68.75
Rank: 5
Range: 2–4 Total: 75
Rank: 1
Range: 2–4 Total: 78.13
Rank: 4
Range: 2–4 Total: 78.13
Rank: 3
67 Rank: 8
10 ACEi versus placebo/no treatment Systolic BP Range: 2–4 Total: 75
Rank: 3
Range: 2–4 Total: 68.75
Rank: 4
Range: 2–4 Total: 75
Rank: 5
Range: 2–3 Total: 68.75
Rank: 9
65.38 Rank: 9
aIs there sufficient capacity to implement the intervention? Is it feasible to provide required training to staff? Rankings are 0 to 4. 4 = optimal (easier to implement), 0 = more difficult
bConsider the level of difficulty with intervention delivery, the infrastructure required (human resources, facilities, etc.). Consider the resources available and whether the intervention is affordable. Rank 0–4, 4 = optimal
(easier/fewer health system effects), 0 = more difficult/greater health system effects,
cIs the intervention relevant to most countries? Rankings are 0 to 4. 4 = Optimal (more generalizable/population-based, 0 = less generalizable/specific population
dDoes the distribution of the disease burden affect mainly the disadvantaged? Are the disadvantaged most likely to benefit from the intervention? Will the intervention improve equity in disease burden distribution
long-term? Rankings are 0 to 4. 4 = Optimal (more generalizable/population-based, 0 = less generalizable/specific population
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more research by prioritizing reviews with potential for
health equity impact for knowledge translation and
broad dissemination.
Consensus was successfully achieved in identifying the
top group of equity-relevant interventions in each of the
five pilot areas. The intent was not to focus on specific
ranking; rather, it was to provide a matrix across these
five criteria to highlight the importance of health equity
in decisions on identifying priority interventions given
limited resources. The next step is to meet with the rele-
vant Campbell and Cochrane review groups, and other
interested systematic review groups, and explore with
them whether and how this process can be incorporated
into their own priority-setting processes for knowledge
translation, as the Cochrane and Campbell Collabora-
tions are both currently developing knowledge transla-
tion strategies for their reviews.
Many Cochrane systematic reviews are focused on
intervention efficacy, and equity concerns are often
more related to intervention implementation and
delivery. Therefore, the evidence in the review may not
relate to its actual importance in practice. To address
this issue, we asked our stakeholders to consider the
feasibility of the intervention, deliverability, universality,
and effects on health equity. We did not include non-
experimental data on harms in this exercise but will in-
clude this information in future updates, when available.
Our methods for this priority-setting exercise are similar
to those used by other groups, such as Child Health and
Nutrition Research Initiative CHNRI [24] and the James
Lind Alliance, which uses priority-setting partnerships to
develop priorities for ten intervention uncertainties for
consideration by research funders [27]. Our approach also
aligns with guidance provided by Lavis et al. for health de-
cision makers (policy and programs) which includes using
explicit criteria based on the underlying problem and bur-
den of disease and intervention options [28]. Other papers
similarly describe priority-setting exercises for research.
These methods include surveys and face-to-face consulta-
tions and evidence mapping [29].
Informing decision makers should involve providing an
easily understood ‘Friendly Front-End’ [13]. Firstly, this de-
rivative summary must provide information on not only
the relative effect or statistical significance alone, but also
the absolute magnitude of the benefits as well as potential
harms, where relevant. Secondly, for those interventions
with meaningful, substantive benefit, policymakers also re-
quire guidance on: a) ease of implementation of the inter-
vention, including the available capacity and human
resources; b) health system requirements and effects on the
health system c) universality – i.e., the magnitude of the
burden of illness in the country of interest. Finally, policy-
makers should be informed about whether the intervention
will reduce health inequities. There is very little research
available on the types of policy summaries and their impact
on policy-makers knowledge and decision-making [30].
Strengths
Each topic area was co-led by an internationally-
recognized “content leader” in the respective content
field (i.e., depression, diabetes/obesity, HIV, malaria, and
nutrition). Each content leader was teamed up with a
Cochrane methodologist with expertise in performing
systematic reviews in the same area. Each team was
composed of a mixture of researchers and policymakers.
The explicit focus on equity was helped by the delinea-
tion of the three additional criteria: a) the ease of imple-
mentation of the intervention, including the available
capacity; b) Health system requirements and effects on
the health system c) Universality, or the magnitude of
the burden of illness in the country of interest. Consen-
sus was achieved remarkably easily on the assessment
criteria. Also, disaggregation of the components contrib-
uting to the total score did not show any one of the
components driving the total score. This may well be
different for a specific country or program where there
are political factors and competing programs.
Challenges/weaknesses
It was challenging building the teams as both leaders and
team members are in great demand; they are all very busy
and typically do not attend Cochrane or other systematic
review meetings. There was no financial payment nor
academic reward beyond this publication. We initially
planned to hold teleconferences but the logistics proved
daunting so although we did meet in person or
electronically with the leaders, the completion of the
worksheets was done asynchronously with the
understanding that if there were major disagreements we
would set up a teleconference to resolve; however, these
were not needed. We had some difficulty getting
agreement on the criteria and definitions from our
stakeholder panel chairs. As mentioned above, some
Stakeholder panel members reported that the wide range
of interventions and outcomes made ranking difficult. If
the Stakeholder Panels had included different stakeholders
this could have changed the priority ranking for some
stakeholders. However, since our Panels included diverse
individuals and were based on consensus, we feel that the
priority lists would have remained similar. Another
limitation of our exercise is that we were mostly limited to
Cochrane reviews, although the nutrition exercise
included some non-Cochrane systematic reviews because
the nutrition stakeholder panel chair identified these as in-
terventions with important effects. The other topic areas
used only Cochrane systematic reviews. Had additional re-
views been included, the results of the exercise may have
differed. However, for this exercise we aimed to conduct a
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priority setting exercise for interventions available in the
Cochrane Library.
This paper has focused on the priority setting
methods for which the process began in 2013. Since
the Cochrane Handbook has not been updated since
then, we believe the methods described in this paper
would be applicable to the current and future priority
setting processes.
Next steps
Our literature will be updated annually and our E4E
summaries will be linked to policy briefs provided through
Health Systems Evidence (www.healthsystemsevidence.org),
a database containing syntheses of research evidence
about governance, financial and delivery arrangements
within health systems, and implementation strategies.
The summaries will also be linked to the
International Initiative for Impact Evaluations (3ie)
Briefs (http://www.3ieimpact.org/en/evidence/briefs/),
which answer policy questions using impact
evaluation results.
This priority-setting exercise will be used to iden-
tify Cochrane systematic reviews that will be summa-
rized and added to the E4E Special Collection
(http://methods.cochrane.org/equity/e4e-series) (Add-
itional file 4: Screenshot of E4E Landing Page and
Additional file 5: Screenshot of HIV Topic Landing
Page). To date, there are 25 pilot summaries avail-
able on the test website. We plan to conduct user
testing of the pilot summaries and will revise the
summaries based on the results, then develop new
summaries for each of the top 10 interventions iden-
tified through the priority-setting exercise.
Conclusions
This method provides an explicit approach to setting
priorities by systematic review groups and funders
for providing decision makers with evidence for the
most important equity-relevant interventions. Sus-
tainability of this E4E special collection will require
partnering with Cochrane and Campbell review
groups to continuously identify systematic reviews
with potential for important impact on health equity.
This could be implemented as part of knowledge
translation strategies for these organizations. A first
step might be to start with interested review groups,
and particularly those covering topics that represent
a high burden of disease in low and middle income
countries.
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